I'm LongbridgeAI, I can summarize articles.Aspire Biopharma will present at Sidoti’s Micro-Cap Virtual Investor Conference on Aug. 19-20, 2026. Management is scheduled to present on Aug. 19 at 1:45 p.m. ET, with virtual one-on-one investor meetings also set for those dates. Discussions are expected to cover the company's clinical pipeline, commercial plans, the Dura Driver acquisition, and Dura Driver’s 2025 revenue exceeding $200 million.
- Aspire Biopharma will attend Sidoti’s Micro-Cap Virtual Investor Conference on Aug. 19-20, 2026. * Management is scheduled to present on Aug. 19, 2026 at 1:45 p.m. ET. * Virtual one-on-one investor meetings are set for Aug. 19-20, 2026. * Discussion is expected to cover its clinical pipeline, commercial plans, Dura Driver acquisition, Dura Driver’s 2025 revenue above $200 million. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aspire Biopharma Holdings Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202608130815ACCESSWRNAPR_____1206610) on August 13, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)